Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-06

Clinical Trial Update: The Effect of 2-DeNT Oral Topical Powder on Minor Recurrent Aphthous Ulcer [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety of 2-DeNT oral topical powder for minor recurrent aphthous stomatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 2-DeNT oral topical powder (2-DeNT)

Snippet

Sponsor: Texas A&M University | Conditions: Minor Recurrent Aphthous Stomatitis Lesions | EARLY_Phase 1 | Status: COMPLETED